AXIS Capital Holdings Limited
AXIS Capital Holdings Limited (AXS) Financial Performance & Income Statement Overview
Review AXIS Capital Holdings Limited (AXS) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
AXIS Capital Holdings Limited (AXS) Income Statement & Financial Overview
Review AXIS Capital Holdings Limited AXS income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.47B | $1.58B | $1.52B | $1.46B |
| Cost of Revenue | $2.73M | $0.00 | $2.73M | $2.73M |
| Gross Profit | $1.46B | $1.58B | $1.52B | $1.46B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $159.16M | $189.19M | $165.20M | $148.44M |
| Operating Expenses | $1.23B | $1.31B | $1.52B | $410.22M |
| Total Costs & Expenses | $1.23B | $1.31B | $1.52B | -$1.18B |
| Interest Income | $236.10M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $16.57M | $16.76M | $16.85M | $17.01M |
| Depreciation & Amortization | $13.79M | $13.13M | $14.28M | $13.64M |
| EBITDA | $266.47M | $296.86M | $258.15M | $275.26M |
| EBITDA Ratio | $0.18 | $0.19 | $0.17 | $0.19 |
| Operating Income | $236.10M | $266.96M | $344.13M | $268.25M |
| Operating Income Ratio | $0.16 | $0.17 | $0.23 | $0.18 |
| Other Income/Expenses (Net) | -$86.35M | $0.00 | -$117.11M | -$1.05B |
| Income Before Tax | $149.75M | $266.96M | $227.03M | $244.61M |
| Income Before Tax Ratio | $0.10 | $0.17 | $0.15 | $0.17 |
| Income Tax Expense | -$44.32M | -$19.41M | $47.92M | $40.55M |
| Net Income | $194.07M | $293.63M | $180.73M | $211.96M |
| Net Income Ratio | $0.13 | $0.19 | $0.12 | $0.15 |
| EPS | $2.30 | $3.43 | $2.06 | $2.42 |
| Diluted EPS | $2.26 | $3.38 | $2.04 | $2.40 |
| Weighted Avg Shares Outstanding | $81.15M | $84.17M | $83.94M | $84.47M |
| Weighted Avg Shares Outstanding (Diluted) | $82.38M | $85.18M | $85.00M | $85.33M |
The company's financials show resilient growth, with revenue advancing from $1.46B in Q2 2024 to $1.47B in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 100% in Q2 2024. Operating income hit $236.10M last quarter, sustaining a consistent 16% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $266.47M. Net income dropped to $194.07M, while earnings per share reached $2.30. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan